Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition
Direct links to NCBI, no account and no request form: the whole study as GSE62726_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 46 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA264968 and SRA study SRP049295. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 46 more — browse all 46 samples with per-sample file links →
- GSE44931 Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers 31 samples
- GSE44929 Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers [Affymetrix] 18 samples
- GSE50625 Targeting transcriptional dependencies in cancer using a covalent CDK7 inhibitor 92 samples
- GSE319641 RNA-Seq profiling of pre- and on-treatment tumor samples from breast cancer patients enrolled in the NeoTRIP trial. 401 samples
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples
- GSE310353 In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment 116 samples
- GSE55064 Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer 83 samples
- GSE34726 Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia 40 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.